section name header

Indications ⬇

High Alert


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: chest pain, hypotension

Derm: dermatologic reactions, erythema, itching

GI: diarrhea, nausea, stomatitis, vomiting

Hemat: leukopenia, thrombocytopenia, anemia, hemolysis

Local: pain/phlebitis at IV site

MS: arthralgia

Neuro: headache

Resp: dyspnea

Misc: chills, fever, serum sickness–like reactions, ANAPHYLAXISALLERGIC REACTIONS INCLUDING , clotted AV fistula, night sweats

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

Route/Dosage ⬆ ⬇

Skin Test

Renal Allograft Recipients

Aplastic Anemia

US Brand Names ⬆ ⬇

ATG, antilymphocyte globulin, Atgam, LIG

Action ⬆ ⬇

  • Decreases the circulating number of T lymphocytes, which are involved in both cell-mediated and humoral immunity.
Therapeutic effects:
  • Resolution of rejection of renal allografts.
  • Remission of aplastic anemia.

Classifications ⬆ ⬇

Therapeutic Classification: Immunosuppressant agents

Pharmacologic Classification: immune globulins

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: 5.7 days.

Time/Action Profile ⬆ ⬇

(decreased circulating T lymphocytes)

ROUTEONSETPEAKDURATION
IVrapidunknownunknown

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

LIM-foe-site im-MYOON GLO-byoo-lin